| Literature DB >> 32982324 |
Ahmed Hazem El-Nagdy1, Gamal M Abdel-Fattah2, Ziad Emarah3.
Abstract
INTRODUCTION: Febrile neutropenia (FN) is the evolution of fever in a patient with neutropenia over 38.0°C. Neutropenia is diagnosed when absolute neutrophil count (ANC) <1500 cells/µL. FN represents a common complication of cancer treatment. Hence, it is featured to be a major cause of morbidity and mortality in cancer patients. Staphylococcus aureus is one of the most important microorganisms isolated from the blood of febrile neutropenic patients. Infections caused by S. aureus range from mild to life-threatening diseases. Biofilm production by S. aureus is one of the most significant virulence factors of the bacterium as it prevents the penetration of antibiotics. Recently, it has been shown that S. aureus carries the ica operon responsible for biofilm production. The aim of the work is to determine a genotypic characterization that includes not only the detection of icaA and icaD genes in S. aureus but also the determination of their relation to clinical and microbiological features. Empiric antibacterial treatment was recommended for cancer patients receiving chemotherapy.Entities:
Keywords: Staphylococcus aureus; biofilm production; febrile neutropenia; icaA; icaD
Year: 2020 PMID: 32982324 PMCID: PMC7495500 DOI: 10.2147/IDR.S259914
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Distribution of 234 Samples Collected from Febrile Neutropenic Patients According to Causative Organism
| Febrile Neutropenic Patients | Number | % | |
|---|---|---|---|
| Causative | 66 | 28.2 | |
| Other Gram-positive | 34 | 14.5 | |
| Gram-negative | 134 | 57.3 |
Type of Isolates According to Congo Red Test
| Colony Color | Result | Conclusion | Number | % |
|---|---|---|---|---|
| Red and dark red | Negative | Non-slime productive bacteria | 18 | 24.4 |
| Black and brown | Positive | Slime productive bacteria | 48 | 72.7 |
Antibiotic Susceptibility of the Isolated Bacteria Against Ten Antibiotics (Interpretation by Inhibition Zone)
| Antibiotic | Inhibition Zone (mm) | No. of Isolates | % | Interpretation |
|---|---|---|---|---|
| Tetracycline (TE) (30 mg) | <11 | 18 | 37.5 | Resistant |
| 12–14 | 15 | 31.25 | Intermediate sensitive | |
| >15 | 15 | 31.25 | Sensitive | |
| Ciprofloxacin (CIP) (5 mg) | <15 | 42 | 87.5 | Resistant |
| 16–20 | 3 | 6.25 | Intermediate sensitive | |
| >21 | 3 | 6.25 | Sensitive | |
| Vancomycin (VA) (30 mg) | <9 | 3 | 6.25 | Resistant |
| 10–11 | 24 | 50 | Intermediate sensitive | |
| >12 | 21 | 43.75 | Sensitive | |
| Erythromycin (E) (15 mg) | <13 | 39 | 81.25 | Resistant |
| 14–22 | – | 0 | Intermediate sensitive | |
| >23 | 9 | 18.75 | Sensitive | |
| Ceftriaxone (CRO) (30 mg) | <13 | 24 | 50 | Resistant |
| 14–20 | 15 | 31.25 | Intermediate sensitive | |
| >21 | 9 | 18.75 | Sensitive | |
| Levofloxacin (LEV) (5 mg) | <13 | 9 | 18.75 | Resistant |
| 14–16 | 30 | 62.5 | Intermediate sensitive | |
| >17 | 9 | 18.75 | Sensitive | |
| Ofloxacin (OFX) (5 mg) | <12 | 39 | 81.25 | Resistant |
| 13–16 | 3 | 6.25 | Intermediate sensitive | |
| >17 | 6 | 12.5 | Sensitive | |
| Ampicillin (AM) (10 mg) | <13 | 36 | 75 | Resistant |
| 14–16 | 9 | 18.75 | Intermediate sensitive | |
| >17 | 3 | 6.25 | Sensitive | |
| Cefoxitin (FOX) (30 mg) | <21 | 42 | 87.5 | Resistant |
| 21–22 | 3 | 6.25 | Intermediate sensitive | |
| >22 | 3 | 6.25 | Sensitive | |
| Linezolid (LZD) (30 mg) | <20 | – | 0 | Resistant |
| 21–22 | 12 | 25 | Intermediate sensitive | |
| >23 | 36 | 75 | Sensitive |
Figure 1Examination of normal bacterial cells under scanning electron microscope.
Figure 2Examination of normal bacterial cells under transmission electron microscope.
Figure 3Examination of treated bacterial cells under scanning electron microscope.
Figure 4Examination of treated bacterial cells under transmission electron microscope.
Distribution of icaA and icaD Genes in Staphylococcal Isolates
| Genes | No of Isolates | % |
|---|---|---|
| 18 | 37.5 | |
| 11 | 22.9 | |
| 5 | 10.4 | |
| Samples carrying at least one | 24 | 50 |
| Total biofilm-productive | 48 | 100 |
Significance of Ages in Cases Carrying at Least One Gene
| Age | Both Genes | |||||
|---|---|---|---|---|---|---|
| Negative (n = 24) | Positive (n = 24) | |||||
| No | % | No | % | |||
| 1–15y | 3 | 12.5% | 0 | 0% | 7.822 | 0.166 |
| 16–30y | 5 | 20.8% | 4 | 16.7% | ||
| 31–45y | 9 | 37.5% | 6 | 25% | ||
| 46–60y | 4 | 16.7% | 5 | 20.8% | ||
| 61–75y | 3 | 12.5% | 6 | 25% | ||
| >75y | 0 | 0% | 3 | 12.5% | ||
| Mean ± SD | 38.92 ± 18.34 | 51.58 ± 17.90 | t = 2.421 | 0.019* | ||
Note: *Significant P < 0.05.
Abbreviations: FN, febrile neutropenia; ANC, absolute neutrophil count; MASCC, Multinational Association for Supportive Care in Cancer; CBC, complete blood picture; SEM, scanning electron microscope; TEM, transmission electron microscope; PCR, polymerase chain reaction.